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Abstract Pulse oximetry screening (POS) has been pro-
posed as an effective, noninvasive, inexpensive tool
allowing earlier diagnosis of critical congenital heart
disease (cCHD). Our aim was to test the hypothesis that
POS can reduce the diagnostic gap in cCHD in daily
clinical routine in the setting of tertiary, secondary and
primary care centres. We conducted a prospective multi-
center trial in Saxony, Germany. POS was performed in
healthy term and post-term newborns at the age of 24–72 h.
If an oxygen saturation (SpO2) of ≤95% was measured on
lower extremities and confirmed after 1 h, complete clinical
examination and echocardiography were performed. POS
was defined as false-negative when a diagnosis of cCHD
was made after POS in the participating hospitals/at our
centre. From July 2006–June 2008, 42,240 newborns from
34 institutions have been included. Seventy-two children
were excluded due to prenatal diagnosis (n=54) or clinical
signs of cCHD (n=18) before POS. Seven hundred ninety-
five newborns did not receive POS, mainly due to early
discharge after birth (n=727; 91%). In 41,445 newborns,
POS was performed. POS was true positive in 14, false
positive in 40, true negative in 41,384 and false negative in
four children (three had been excluded for violation of
study protocol). Sensitivity, specificity, positive and nega-
tive predictive value were 77.78%, 99.90%, 25.93% and
99.99%, respectively. With POS as an adjunct to prenatal
diagnosis, physical examination and clinical observation,
the percentage of newborns with late diagnosis of cCHD
was 4.4%. POS can substantially reduce the postnatal
diagnostic gap in cCHD, and false-positive results leading
to unnecessary examinations of healthy newborns are rare.
POS should be implemented in routine postnatal care.
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Introduction
Diagnosis and treatment of congenital heart disease have
changed dramatically over the last few decades. The relative
importance of preoperative morbidity and mortality has been
increasing as a result of the great improvements in perioper-
ative and long-term survival. This is especially true for critical
congenital heart disease (cCHD), a group of morphologically
heterogeneous disorders which have in common that early
surgical or catheter interventional therapy is mandatory to
achieve survival. Clinical examination is unable to detect all
forms of cCHD [1, 32]. Heart murmurs, one of the hallmarks
of non-critical heart disease typically diagnosed later in life
may be absent or misleading because of the underlying
anatomy, prolonged decline of pulmonary vascular resistance
or reduced ventricular function. Despite the increasing use of
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prenatal diagnosis, a significant proportion of affected
newborns is still not diagnosed before discharge after birth
[7, 31]. This problem may be aggravated by recent trends to
earlier discharge and other changes in postnatal care [20].
The first manifestation of cCHD may be acute with
circulatory collapse and the need for cardiopulmonary
resuscitation or death, i.e. delayed diagnosis is associated
with significant morbidity and mortality [4, 6, 16, 18]. The
current incidence of severe physiologic compromise resulting
from previously unrecognised cCHD has been estimated to
be 1 per 15,000 to 1 per 26,000 live births [27]. Hence, there
is broad consensus that screening for cCHD is warranted [17,
27, 29, 30]. However, it has been argued that “the use of
prenatal ultrasound, close clinical observation during the
transitional period and thorough physical examination alone”
may be sufficient for timely diagnosis of cCHD [28]. This
may be true in the specific setting of this single centre study,
but the prerequisites mentioned are probably not encountered
in the majority of hospitals or maternity units [25].
Pulse oximetry can detect mild hypoxemia, which is
characteristic for many forms of cCHD, and may not be
recognised by clinical examination [21]. The first abstracts
examining pulse oximetry as a screening tool for cCHD
were published in 1995 [5, 14]. Since then, there has been
an increasing number of single and oligocentric studies on
the subject [2, 3, 13, 15, 19, 23, 24, 26]. Despite differences
among the study protocols concerning target lesions, time
of screening, cut-off values, probe placement and others,
most authors came to the conclusion that pulse oximetry
screening (POS) is a useful method. Recently published
meta-analyses tend to share this view but argued that
existing evidence is still insufficient to support a general
recommendation for implementation of POS in routine care
and therefore stated a need for further data [17, 29, 30].
The aim of our study was to test the hypothesis that POS,
using currently available pulse oximeters, can effectively
reduce the diagnostic gap in cCHD in daily clinical routine in
centres of primary, secondary and tertiary care.
Materials and methods
A prospective multicenter field study of 34 neonatal/obstetri-
cal departments in Saxony, Germany, was performed from
July 2006 to June 2008. All full and post-term neonates
(gestational age ≥37 weeks) meeting the following criteria
were included in the study: (1) no prenatal diagnosis/suspicion
of congenital heart disease, (2) normal routine clinical
examination (3) informed parental consent.
All forms of cCHD were defined as the target of POS,
regardless of whether cyanosis, i.e. duct dependency, is an
invariable or a possible feature of the particular condition
(Table 1).
At the age of 24–72 h, POS was performed by midwives,
nurses and physicians experienced in the routine use of pulse
oximetry. No particular requirements concerning the type of
pulse oximeter were made so that a great variety of devices
was used. All pulse oximeters measured functional oxygen
saturation (SpO2). The probe was placed on either foot. A
SpO2 of ≥96% was defined as normal. POS was positive
when a SpO2 of ≤95% was measured and confirmed after
1 h. POS results were recorded in each newborn’s hospital
chart as well as in its individual booklet for prevention
during childhood and adolescence (“Gelbes Heft”). A
positive POS was followed by complete clinical examination
and echocardiography. After negative POS, no further
actions were taken. POS was defined as false-negative when
a diagnosis of cCHD was made after POS in the participating
hospitals/at our centre.
Data acquisition was performed at the study sites, at the
central office for quality management in perinatal and neonatal
care of the Saxonian Medical Association and at our hospital,
which is the referral centre for participants of the study. Data
analysis and descriptive statistics were performed using
commercially available software (Microsoft® Excel® 2008
for Mac). Sensitivity, Specificity, positive and negative
predictive values for POS were calculated.
The study protocol was approved by the Ethics Com-
mittee of the University of Leipzig, Germany.
Results
During the study period, there were 48,348 live births in the
participating hospitals. A total of 6,108 newborns were
excluded from the study. Of these, 54 had prenatal
diagnosis of cCHD. In 18 of them, clinical symptoms led
Table 1 Types of critical congenital heart disease (cCHD) defined as
target lesions for pulse oximetry screening (POS)
Duct-dependent systemic circulation
Interrupted aortic arch
Complex/critical coarctation of the aorta
Hypoplastic left heart syndrome
Critical aortic valve stenosis
Duct-dependent pulmonary circulation
Pulmonary atresia—various forms
Variants of congenital heart disease with severe pulmonary
stenosis/atresia
Critical pulmonary valve stenosis
Total anomalous pulmonary venous drainage
Transposition of the great arteries
Complex cyanotic congenital heart disease
Transposition of the great arteries—ventricular septal defect
Functional univentricular heart—various forms
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to the diagnosis of cCHD before POS. A total of 6,036
newborns received diagnosis/treatment for other conditions.
No parents refused to participate in the study.
Newborns eligible for POS, 42,240 of them, were included
in the study. Seven hundred ninety-five did not receive POS,
mainly because of early discharge after birth (n=727; 91%). A
total of 41,445 newborns received POS. Three children were
excluded from further analysis because the study protocol
had not been correctly followed. Pulse oximetry had been
performed in these three early on the first day of life (i.e. at
an age of 4, 6 and 10 h, respectively) resulting in SpO2
ranging from 94% to 95% at initial and control measurement.
All were discharged early (one after exclusion of cCHD by
echocardiography), and none was re-admitted for cCHD. A
SpO2 of ≤95% was measured in 65 (0.16%) of 41,442
neonates. This measurement was confirmed, i.e. POS was
positive in 54 (0.13%) of 41,445 neonates. POS was false-
positive related to the diagnosis of cCHD in 40 newborns
(healthy n=12, persistent pulmonary hypertension of the
newborn n=15, sepsis n=13). POS was true-positive in 14
children (Fig. 1 and Table 2). The types of cCHD detected by
POS are listed in Table 2. POS was true-negative in 41,384
and false-negative in four children (Table 3). The latter were











































Fig. 1 Flow chart of the study
population
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(n=3) discharge from the maternity unit. The patient with
transposition of the great arteries and ventricular septal defect
presented with dyspnea and cyanosis: prostaglandin was in-
fused. The patients with coarctation had severe circulatory
impairment necessitating catecholamine support and/or me-
chanical ventilation. All were transferred to our hospital and
subsequently underwent successful cardiac surgery.
Sensitivity, specificity, positive and negative predictive
value for POS were 77.78%, 99.90%, 25.93% and 99.99%,
respectively.
The incidence of cCHD (n=90) in the study population
(n=48,348) was 0.186%. The modes of diagnosis are
summarised in Fig. 2. In the perinatal and neonatal
registries, maintained at the Saxonian Medical Association,
there was no death resulting from cCHD outside of our
centre, i.e. any being related to delayed diagnosis or non-
referral among our study population.
Discussion
The total number of patients, in whom POS has been
assessed for earlier detection of cCHD exceeds 150,000 [9,
17]. Our study differs from most of the previously
published reports mainly in that we included 42,240
newborns, which is comparable only to recent data from
Meberg and de-Wahl Granelli [9, 19]. Furthermore, a broad
spectrum of hospitals providing primary, secondary or
tertiary care participated in our study with the aim of
examining whether POS is able to reduce the diagnostic
gap in cCHD not only in controlled single or oligocentric
studies but also under “real life” conditions.
In our study, there was a relatively high percentage of
cCHD detected by prenatal ultrasound (60%). It would be
of interest to know which results would have been obtained
by POS in these newborns. However, when a prenatal
diagnosis of cCHD is made, perinatal management is
planned as soon as parents opt for postnatal therapy (and
not for abortion or compassionate care). After delivery,
these newborns receive immediate medical assessment and
treatment if the diagnosis is confirmed. Treatment frequent-
ly consists of prostaglandin infusion and volume replace-
ment and may include catheter interventions (balloon
atrioseptostomy of a restrictive foramen ovale, balloon
angioplasty of critical valvular stenoses and, rarely, stenting
of restrictive communications at the atrial or ductal level).
SpO2 is an important target in the postnatal management of
cCHD. It is kept within the normal range in non-cyanotic
lesions, whereas in many cyanotic lesions, an attempt is
made to maintain pulmonary to systemic flow ratio at 1:1
(corresponding to an SpO2 of about 80%). Thus, SpO2 in
these newborns rather reflects the underlying hemodynam-
ics and the quality of postnatal care. It does not answer the
question whether these children would have been detected
by POS (or by previous clinical observation/physical
examination). This would only have been possible if the
prenatal diagnosis and postnatal care had been withheld,
which obviously was not feasible for ethical reasons.
Table 2 Types of critical congenital heart disease (cCHD) detected by
pulse oximetry screening (POS) (n=14)
Duct-dependent systemic circulation 2
Persistent truncus arteriosus, interrupted aortic arch 1
Hypoplastic left heart syndrome 1
Duct-dependent pulmonary circulation 2
Pulmonary atresia, ventricular septal defect
Total anomalous pulmonary venous drainage 5
Transposition of the great arteries 2
Complex cyanotic congenital heart disease 3
Transposition of the great arteries—ventricular septal defect 2
Taussig–Bing syndrome 1
Fig. 2 Reduction of the “diagnostic gap” in critical congenital heart
disease (cCHD) with pulse oximetry screening. All newborns with
critical cCHD (n=90 out of the study population (n=48,348)) are
shown. Colours indicate in percentages whether the diagnosis was
made by prenatal ultrasound (prenatal), by physical examination or
clinical observation (clinical) before pulse oximetry screening, i.e.
during the first 24 h of life or by pulse oximetry screening (POS).
When POS was used, only 4.4% of newborns had a delayed diagnosis
of cCHD (diagnostic gap)
Table 3 Types of critical congenital heart disease (cCHD) missed by
pulse oximetry screening (POS) (n=4)
Duct-dependent systemic circulation 3
Critical coarctation of the aorta 2
Complex coarctation of the aorta—ventricular septal defect 1
Complex cyanotic congenital heart disease 1
Transposition of the great arteries—ventricular septal defect 1
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After the first physical examination and clinical obser-
vation during the first 24 h of life, i.e. before POS was
performed, 80% of all cCHD had been diagnosed. A second
physical examination before discharge from maternity is
current practice in our as well in many other regions.
However, this does not seem to increase the sensitivity
which can be achieved with this method [10]. Thus, it
seems reasonable to assume that the diagnostic gap without
POS would have remained at 20%, which is in agreement
with the data reported by Wren [31]. Using POS to
complement prenatal ultrasound and physical examination/
clinical observation achieved a diagnostic gap as low as
4.4% (Fig. 2). We believe that this number is more
important than the sensitivity of POS alone, which was
77.78% in our study and is comparable to other large series
[9, 15, 19]. This relates to the fact that the reduction of the
diagnostic gap in cCHD reflects the aim of POS—at least
from a clinician's perspective. Unlike other methods, for
example, newborn metabolic or hearing screening POS is
not meant as a new test for more or less replacing other
existing methods. Rather, it can be thought of as a tool
which is complementary to prenatal ultrasound, physical
examination and clinical observation. It has been well
documented that POS sometimes does not detect left heart
obstructive lesions which represented 75% of the false-
negative cases in our series [30]. This is not surprising, as
for example coarctation of the aorta may develop and
progress early after birth and is not always duct-dependent.
Nevertheless, in some cases, there is right to left shunting
via a patent arterial duct; for this reason we did not exclude
these lesions from the target group. We would like to
underscore the idea that POS is a complementary tool and
that thorough physical examination should not only include
the search for signs of heart failure but also comparative
pulse palpation. Complex cyanotic lesions can be also be
missed by POS alone, especially in the context of high
pulmonary blood flow. However, concomitant clinical
examination may detect tachypnea and prompt further
evaluation [12].
Not surprisingly, sensitivity and reliability of POS may
also be influenced by human factors, and the training level
of the staff performing POS should be adequate [22].
The rate of false-positive results in our study was very
low (0.10%). Others reported similar results [9, 15].
Furthermore, some of these neonates had other diseases,
like neonatal sepsis, for which earlier diagnosis does no
harm. It has also been shown that earlier screening leads to
a higher percentage of false-positive results [19]. Therefore,
most publications, including one large review, recommend
that POS be performed at or after 24 h of age [9, 15, 30].
It has been argued that POS should be done with a new-
generation pulse oximeter [8]. On the other hand, existing
technology is used to monitor critically ill children and to
guide intensive care and theoretical differences may not
always be clinically relevant [30]. In our study—undertak-
en with a great variety of pulse oximeters—the percentage
of cCHD diagnosed before discharge from maternity was
even higher than in the Swedish study, where new-
generation pulse oximeters were used (95.6 vs. 92%) [9].
Most authors currently use a high cut-off value of 95%
or 96%, at which level POS seems to have the best overall
performance [2, 9, 15, 19, 23, 24, 26]. Between these two
values, differences are probably minimal, and with a higher
cut-off, the need for measurement of pre- and postductal
difference in SpO2 decreases [30]. However, postductal
measurement is important, as some forms of cCHD
associated with predominant right to left shunting at ductal
level may be missed when only preductal SpO2 is used.
Our study protocol included repeated SpO2 measurements
after 1 h if the initial value was <96%. This reduced the
number of newborns undergoing clinical examination and
echocardiography from 65 to 54. After having accumulated
more data, further analyses may show that in newborns with
an SpO2 below a certain threshold, assessment should be
initiated directly without repeated measurements.
In our study, we did not address the issue of costs which
has been extensively examined by Griebsch et al. who came
to the conclusion that POS is at least cost-neutral in the
short term [11]. Taking into account the financial burden of
death and sequelae of neurologic impairment or disability,
which may result from late diagnosis of cCHD, POS should
be cost effective [29, 30].
In reviewing our data and the experience published by
others, we agree that there remain some open questions
concerning the use of POS. On the other hand, using
currently available pulse oximeters POS as an adjunct to
prenatal ultrasound, thorough physical examination and
clinical observation can substantially reduce the diagnostic
gap in cCHD. In view of the persisting problem of late
diagnosis of cCHD and its potential sequelae, we think it is
no longer justified to withhold this method. We would
rather suggest that POS be implemented in routine neonatal
care while scientific evaluation of the method is continued
to allow for modifications. In Saxony, after the end of our
study, an appropriate recommendation has been put forward
by the Working Groups for Perinatology and Neonatology
of the Saxonian Medical Association.
Limitations of the study
During the study period, there were no reports of suspected
death from unrecognised cCHD from the participating
hospitals. In the Saxonian perinatal and neonatal registries,
there were no deaths in external hospitals resulting from
cCHD among our study population. Due to statutory
provisions, there is no compulsory autopsy in our region.
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We, therefore, cannot fully exclude single missed cases of
death from undiagnosed cCHD. Additionally, after dis-
charge from a maternity unit, there may have been re-
admissions for cCHD in hospitals in other regions, i.e. not
covered by Saxonian registries. However, the incidence of
cCHD in our population was rather high compared to what
should be expected from published reports. We can
therefore assume that any potential resulting error is small.
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